Reactive eccrine syringofibroadenoma in an elderly patient
DOI:
https://doi.org/10.25251/e3se2k28Keywords:
chronic lymphedema, eccrine syringofibroadenoma, nodules, ulcerationAbstract
Eccrine syringofibroadenoma (ESFA) is an uncommon benign adnexal tumor with eccrine differentiation, with fewer than 100 cases reported worldwide. Since its initial description, several clinical subtypes have been recognized, including a reactive form associated with chronic inflammatory or neoplastic conditions. We report the case of an 88-year-old man with extensive reactive ESFA developing in the setting of long-standing postthrombotic lymphedema and neglected ulceration. The patient presented with poor general health, bilateral pleural effusions, multiple verrucous nodules, severe stasis ulcers, and secondary polymicrobial and fungal infections. Histopathologic examination of a nodule demonstrated interconnecting cords of cuboidal epithelial cells with ductal structures within a fibrovascular stroma, consistent with eccrine differentiation and diagnostic of ESFA. Management focused on infection control, wound care, and supportive therapy, as surgical excision and amputation were not suitable options. Clinical improvement was achieved; however, ongoing monitoring was advised because of the potential for malignant transformation. This case highlights the role of chronic tissue injury in the pathogenesis of reactive ESFA and underscores the importance of histopathology for diagnosis, multidisciplinary collaboration in management, and individualized treatment planning in elderly patients with advanced comorbidities.
References
1. Kim TE, Ahn HJ, Shin MK. A Case of Eccrine Syringofibroadenoma Related to Senile Gluteal Dermatosis. Ann Dermatol. 2023;35(Suppl 2):S205-S207. doi:10.5021/ad.21.229. PMID:38061704
2. Mascaró JM. Considerations on fibro-epithelial tumors: exocrine syringofibradenoma [French]. Ann Dermatol Syphiligr (Paris). 1963;90:143-153. PMID:13933264
3. Starink TM. Eccrine syringofibroadenoma: multiple lesions representing a new cutaneous marker of the Schöpf syndrome, and solitary nonhereditary tumors. J Am Acad Dermatol. 1997;36(4):569-576. doi:10.1016/s0190-9622(97)70245-70247. PMID:9092743
4. French LE. Reactive eccrine syringofibroadenoma: an emerging subtype. Dermatology. 1997;195(4):309-310. doi:10.1159/000245977. PMID:9529546
5. Blaise M, Huard E, Cardot-Leccia N, et al. Recalcitrant erosive palms and soles eccrine syringofibroadenoma successfully treated with radiotherapy. J Eur Acad Dermatol Venereol. 2025;39(4):e323-e325. doi:10.1111/jdv.20301. PMID:39166917
6. Bjarke T, Ternesten-Bratel A, Hedblad M, Rausing A. Carcinoma and eccrine syringofibroadenoma: a report of five cases. J Cutan Pathol. 2003;30(6):382-392. doi:10.1034/j.1600-0560.2003.00072.x. PMID:12834488
7. Silveira CSCD, Santos LFO, D’Elia MLN, Obadia DL. Eccrine syringofibroadenoma: report of two exuberant cases. An Bras Dermatol. 2024;99(3):467-471. doi:10.1016/j.abd.2022.10.017. PMID:38403553
Downloads
Published
Data Availability Statement
The data presented in the manuscript are available from the corresponding author upon reasonable request.
Issue
Section
License
Copyright (c) 2026 Valbona Zeneli, Arben Zeneli, Ermira Vasili, Sabina Dedej (Author)

This work is licensed under a Creative Commons Attribution 4.0 International License.
